Positions

Selected Publications

Academic Article

Year Title Altmetric
2017 Phenotype and function of myeloidderived suppressor cells induced by Porphyromonas gingivalis infectionInfection and Immunity.  85. 2017
2017 CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathwayPLoS ONE.  12. 2017
2015 IL-1R/TLR2 through MyD88 divergently modulates osteoclastogenesis through regulation of nuclear factor of activated T cells c1 (NFATc1) and B lymphocyte-induced maturation protein-1 (Blimp1)Journal of Biological Chemistry.  290:30163-30174. 2015
2013 Role of mTOR downstream effector signaling molecules in Francisella tularensis internalization by murine macrophagesPLoS ONE.  8. 2013
2013 Role of TLR2-dependent IL-10 production in the inhibition of the initial IFN-γ T cell response to porphyromonas gingivalisJournal of Leukocyte Biology.  93:21-31. 2013
2012 A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVSPLoS ONE.  7. 2012
2011 Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activationInfection and Immunity.  79:3792-3800. 2011
2011 TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-κBJournal of Biological Chemistry.  286:24159-24169. 2011
2011 TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin BJournal of Immunology.  186:5772-5783. 2011
2010 Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccineVaccine.  28:4928-4936. 2010
2009 Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalisMolecular Immunology.  46:2493-2504. 2009
2009 Glycogen synthase kinase-3β (GSK3β) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in miceMolecular Immunology.  46:677-687. 2009
2008 TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensisJournal of Leukocyte Biology.  84:1434-1446. 2008
2007 Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid AVaccine.  25:6201-6210. 2007
2006 Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter systemVaccine.  24:5003-5015. 2006
2006 Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVSInfection and Immunity.  74:2809-2816. 2006
2005 Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalisVaccine.  23:4734-4744. 2005
2005 Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin BInfection and Immunity.  73:3990-3998. 2005
2004 Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalisInfection and Immunity.  72:637-644. 2004
2003 Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalisVaccine.  21:4459-4471. 2003
2003 Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharideJournal of Immunology.  171:717-725. 2003
2003 Role of innate immune factors in the adjuvant activity of monophosphoryl lipid AInfection and Immunity.  71:2498-2507. 2003
2003 Bacterial invasion by a paracellular route: Divide and conquerMicrobes and Infection.  5:613-619. 2003
2003 Feasibility of an HA2 domain-based periodontitis vaccineInfection and Immunity.  71:562-566. 2003
2002 Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infectionInfection and Immunity.  70:6779-6787. 2002
2002 Microbial/host interactions: Mechanisms involved in host responses to microbial antigensImmunologic Research.  26:223-234. 2002
2002 Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalisInfection and Immunity.  70:3557-3565. 2002
2002 Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipainsInfection and Immunity.  70:2512-2518. 2002
2001 Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coliJournal of Immunology.  167:5278-5285. 2001
2001 A vaccine against dental caries: An overviewClinical immunotherapeutics.  15:501-508. 2001
2000 Cytokine profiles in parotid saliva from HIV-1-infected individuals: Changes associated with opportunistic infections in the oral cavityOral Microbiology and Immunology.  15:74-81. 2000
2000 Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexesInfection and Immunity.  68:1441-1449. 2000
1999 Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat modelInfection and Immunity.  67:4352-4359. 1999
1998 Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalisOral Microbiology and Immunology.  13:73-80. 1998
1997 Passive Immunization against Dental Plaque Formation in Humans: Effect of a Mouth Rinse Containing Egg Yolk Antibodies (IgY) Specific to Streptococcus mutansCaries Research.  31:268-274. 1997
1996 Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalisOral Microbiology and Immunology.  11:309-318. 1996
1996 Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine modelOral Microbiology and Immunology.  11:274-281. 1996
1995 Induction of salivary IgA responses to Streptococcus mutans antigen I/II after intranasal immunizationAdvances in Experimental Medicine and Biology.  371:1153-1156. 1995
1995 Oral immunization studies with streptococcus mutans and influenza vaccines in rhesus macaque monkeysAdvances in Experimental Medicine and Biology.  371:1423-1429. 1995
1993 Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxinInfection and Immunity.  61:1964-1971. 1993
1992 Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responsesAdvances in Experimental Medicine and Biology.  327:191-198. 1992
1992 Humoral response to Porphyromonas (Bacteroides) gingivalis in rats: Time course and T-cell dependenceInfection and Immunity.  60:3579-3585. 1992
1991 A method for generating antigen-specific rat T helper cell clonesJournal of Immunological Methods.  138:77-86. 1991
1991 Effect of immune bovine milk on Streptococcus mutans in human dental plaqueArchives of Oral Biology.  36:41-47. 1991
1990 Characterization of rat T helper cell clones specific for Bacteroides gingivalis antigenInfection and Immunity.  58:2785-2791. 1990
1989 Liposomes as oral adjuvants.Current Topics in Microbiology and Immunology.  146:51-58. 1989
1987 Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptocococcus mutansInfection and Immunity.  55:2341-2347. 1987
1987 Novel oral vaccines: the effectiveness of cloned gene products on inducing secretory immune responses.Advances in Experimental Medicine and Biology.  216 B:1741-1747. 1987
1987 Oral vaccines and the secretory immune systemClinical Immunology Newsletter.  8:158-159. 1987
1985 Cleavage of bovine skin type III collagen by proteolytic enzymes. Relative resistance of the fibrillar formJournal of Biological Chemistry.  260:16411-16417. 1985

Education And Training

  • Doctor of Philosophy in Immunopathology Residency Program, University of Alabama at Birmingham 1992
  • Doctor of Dental Science in Dentistry, National Autonomous University of Mexico 1980
  • Full Name

  • Jannet Katz